β-Blockade improves adjacent regional sympathetic innervation during postinfarction remodeling

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 277, Issue 4 46-4, 1999, Pages

  Kramer, Christopher M ^a,b   Nicol, Philip D ^a   Rogers, Walter J ^a   Seibel, Philip S ^a   Park, Chong S ^a   Reichek, Nathaniel ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Magnetic resonance imaging; Myocardial contraction; Myocardial infarction; Remodeling

Indexed keywords

GUANIDINE DERIVATIVE; METOPROLOL; RAMIPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART CONTRACTION; HEART EJECTION FRACTION; HEART INDEX; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; NONHUMAN; PRIORITY JOURNAL; SHEEP; SYMPATHETIC INNERVATION;

EID: 0032753526     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.277.4.h1429     Document Type: Article

References (36)

1. Axel, L., and L. Dougherty. MR imaging of motion with spatial modulation of magnetization. Radiology 171: 841-845, 1989.
2. Beta-Blocker Heart Attack Trial Research Group. Arandomized trial of propranolol in patients with acute myocardial infarction: mortality results. JAMA 247: 1707-1714, 1982.
3. Eaton, L. W., J. L. Weiss, B. H. Bulkley, J. B. Garrison, and M. D. Weisfeldt. Regional cardiac dilatation after acute myocardial infarction. N. Engl. J. Med. 300: 57-62, 1979.
4. Erlebacher, J. A., J. L. Weiss, L. W. Eaton, C. Kallman, M. L. Weisfeldt, and B. H. Bulkley. Late effects of acute infarct dilation on heart size: a two dimensional echocardiographic study. Am. J. Cardiol. 49: 1120-1126, 1982.
5. First International Study of Infarct Survival Collaborative Group. A randomized trial of intravenous atenolol among 16,207 cases of suspected acute myocardial infarction: ISIS-1. Lancet 2: 57-66, 1986.
6. Fishbein, M. C., L. Q. Lei, and S. A. Rubin. Long-term propranolol administration alters myocyte and ventricular geometry in rat hearts with and without infarction. Circulation 78: 369-375, 1988.
7. Hartikainen, J., J. Kuikka, M. Mantysaari, E. Lansimies, and K. Pyorala. Sympathetic reinnervation after acute myocardial infarction. Am. J. Cardiol. 77: 5-9, 1996.
8. Heilbrunn, S. M., P. Shah, M. R. Bristow, H. A. Valentine, R. Ginsburg, and N. B. Fowler. Increased β-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation 79: 483-490, 1989.
9. Hu, K., P. Gaudron, and G. Ertl. Long-term effects of beta-adrenergic blocking agent treatment on hemodynamic function and left ventricular remodeling in rats with experimental myocardial infarction. J. Am. Coll. Cardiol. 31: 692-700, 1998.
10. Kober, L., C. Torp-Peedersen, J. E. Carlsen, H. Bagger, P. Eliasen, K. Lyngborg, J. Videbaek, D. S. Cole, L. Auclert, and N. C. Pauly. A clinical trial of the angiotensin-converting-enzyme inhibitor in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N. Engl. J. Med. 333: 1670-1676, 1995.
11. Kozlovskis, P. L., M. J. D. Smets, R. C. Duncan, B. E. Bailey, A. L. Bassett, and R. J. Myerburg. Regional beta-adrenergic receptors and adenylate cyclase activity after healing of myocardial infarction in cats. J. Mol. Cell. Cardiol. 22: 311-322, 1990.
12. Kramer, C. M., V. A. Ferrari, W. J. Rogers, T. Theobald, M. L. Nance, L. Axel, and N. Reichek. Angiotensin converting enzyme inhibition limits adjacent noninfarcted region dysfunction during left ventricular remodeling. J. Am. Coll. Cardiol. 27: 211-217, 1996.
13. Kramer, C. M., J. A. C. Lima, N. Reichek, V. A. Ferrari, M. R. Llaneras, L. C. Palmon, I.-T. Yeh, B. Tallant, and L. Axel. Regional function within noninfarcted myocardium during left ventricular remodeling. Circulation 88: 1279-1288, 1993.
14. Kramer, C. M., P. D. Nicol, W. J. Roger, M. Suzuki, A. Shaffer, T. M. Theobald, and N. Reichek. Reduced sympathetic innervation underlies adjacent noninfarcted region dysfunction during left ventricular remodeling. J. Am. Coll. Cardiol. 30: 1079-1085, 1997.
15. Kramer, C. M., W. J. Rogers, C. S. Park, P. S. Seibel, A. Shaffer, T. M. Theobald, N. Reichek, T. Onadero, and A. M. Gerdes. Regional myocyte hypertrophy parallels regional myocardial dysfunction during post-infarct remodeling. J. Mol. Cell. Cardiol. 30: 1773-1778, 1998.
16. McDonald, K. M., T. Rector, P. F. Carlyle, G. Francis, and J. N. Cohn. Angiotensin-converting enzyme inhibition and beta-adrenoceptor blockade regress established ventricular remodeling in a canine model of discrete myocardial damage. J. Am. Coll. Cardiol. 24: 1762-1768, 1994.
17. McKay, R. G., M. A. Pfeffer, R. C. Pasternak, J. E. Markis, P. C. Come, S. Nakao, J. D. Alderman, J. J. Ferguson, R. D. Safian, and W. Grossman. Left ventricular remodeling following myocardial infarction: a corollary to infarct expansion. Circulation 74: 693-702, 1986.
18. Minardo, J. D., M. M. Tuli, B. H. Mock, R. E. Weiner, H. P. Pride, H. N. Wellman, and D. P. Zipes. Scintigraphic and electrophysiological evidence of canine myocardial sympathetic denervation and reinnervation produced by myocardial infarction or phenol application. Circulation 78: 1008-1019, 1988.
19. Mitchell, G. F., G. A. Lamas, D. E. Vaughan, and M. A, Pfeffer. Left ventricular remodeling in the year after first anterior myocardial infarction. J. Am. Coll. Cardiol. 19: 1136-1144, 1992.
20. Norwegian Multicentre Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N. Engl. J. Med. 304: 801-807, 1981.
21. Oh, B. H., S. Ono, E. Gilpin, and J. Ross, Jr. Altered left ventricular remodeling with β-adrenergic blockade and exercise after coronary reperfusion in rats. Circulation 87: 608-616, 1993.
22. Pfeffer, M. A., and E. Braunwald. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81: 1161-1172, 1990.
23. Pfeffer, M. A., E. Braunwald, L. A. Moye, L. Basta, E. J. Brown, T. E. Cuddy, B. R. Davis, E. M. Geltman, S. Goldman, G. C. Flaker, M. Klein, G. A. Lamas, M. Packer, J. Rouleau, J. L. Rouleau, J. Rutherford, J. H. Wertheimer, and C. M. Hawkins. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 327: 669-677, 1992.
24. Pfeffer, M. A., J. M. Pfeffer, C. Steinberg, and P. Finn. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 72: 406-412, 1985.
25. Sabbah, H. N., H. Shimoyama, T. Kono, R. C. Gupta, V. G. Sharov, G. Scicli, T. B. Levin, and S. Goldstein. Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction. Circulation 89: 2852-2859, 1994.
26. Spargias, C. S., A. S. Hall, and S. G. Ball. Beta-blocker therapy in patients with clinical evidence of heart failure after acute myocardial infarction (Abstract). J. Am. Coll. Cardiol. 31: 32A, 1998.
27. 123Imetaiodobenzylguanidine. J. Am. Coll. Cardiol. 14: 1519-1526, 1989.
28. St. John Sutton, M., M. A. Pfeffer, T. Plappert, J. L. Rouleau, L. A. Moye, G. R. Dagenais, G. A. Lamas, M. Klein, B. Sussex, S. Goldman, F. J. Menapace, Jr., J. O. Parker, S. Lewis, F. Sestier, D. F. Gordon, P. McEwan, V. Bernstein, and E. Braunwald. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. Circulation 89: 68-75, 1994.
29. 131metaiodobenzylguanidine after ischemia and reperfusion in anesthetized dogs. J. Nucl. Cardiol. 4: 35-41, 1997.
30. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342: 821-828, 1993.
31. Uretsky, B. F., and R. G. Sheahan. Primary prevention of sudden cardiac death in heart failure: will the solution be shocking? J. Am. Coll. Cardiol. 30: 1589-1597, 1997.
32. Vantrimpont, P., J. L. Rouleau, C.-C. Wun, A. Ciampi, M. Klein, B. Sussex, J. M. O. Arnold, L. Moye, and M.A. Pfeffer for the SAVE Investigators. Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) study. J. Am. Coll. Cardiol. 29: 229-236, 1997.
33. 123IMIBG). In: Chemists' Views of Imaging Centers, edited by A. M. Emran. New York: Plenum, 1995, p. 291-298.
34. Yonemochi, H., S. Yasunaga, T. Teshima, T. Iwao, K. Akiyoshi, M. Nakagawa, T. Saikawa, and M. Ito. Mechanism of β-adrenergic receptor upregulation induced by ACE inhibition in cultured neonatal rat cardiac myocytes. Circulation 97: 2268-2273, 1998.
35. Yusuf, S., R. Peto, J. Lewis, R. Collins, and P. Sleight. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog. Cardiovasc. Dis. 27: 335-371, 1985.
36. Zerhouni, E., D. Parrish, W. J. Rogers, A. Yang, and E. P. Shapiro. Human heart: tagging with MR imaging - a method for noninvasive measurement of myocardial motion. Radiology 169: 59-64, 1988.